Click for best price
Urinary System Drugs Market Size, Share 2023
The global Urinary System Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The USA market for Global Urinary System Drugs market is estimated to increase from USD million in 2022 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
The China market for Global Urinary System Drugs market is estimated to increase from USD million in 2022 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
The Europe market for Global Urinary System Drugs market is estimated to increase from USD million in 2022 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
This report aims to provide a comprehensive presentation of the global market for Urinary System Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Urinary System Drugs.
This report contains market size and forecasts of Urinary System Drugs in global, including the following market information:
- Global Urinary System Drugs Market Revenue, 2018-2023, 2024-2030, ($ millions)
- Global top five companies in 2022 (%)
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Injection Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Urinary System Drugs include Johnson & Johnson, Bayer, Pfizer, GSK, Boehringer Ingelheim, Roche, Novartis, AstraZeneca and Dr. Reddy?s Laboratories, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Urinary System Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Urinary System Drugs Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Urinary System Drugs Market Segment Percentages, by Type, 2022 (%)
- Injection
- Tablets
- Capsule
- Suppository
- Granules
- Powder
- Pills
- Cream
- Others
Global Urinary System Drugs Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global Urinary System Drugs Market Segment Percentages, by Application, 2022 (%)
- Kidney Disease Medication
- Medication For Prostate Disease
- Male Dysfunction
- Lithotripsy Drug
- Others
Global Urinary System Drugs Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global Urinary System Drugs Market Segment Percentages, By Region and Country, 2022 (%)
- North America (United States, Canada, Mexico)
- Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe)
- Asia-Pacific (China, India, Japan, South Korea, Australia, Rest of APAC)
- The Middle East and Africa (Middle East, Africa)
- South and Central America (Brazil, Argentina, Rest of SCA)
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Urinary System Drugs revenues in global market, 2018-2023 (estimated), ($ millions)
- Key companies Urinary System Drugs revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Johnson & Johnson
- Bayer
- Pfizer
- GSK
- Boehringer Ingelheim
- Roche
- Novartis
- AstraZeneca
- Dr. Reddy?s Laboratories
- Mylan
- Sun Pharma
- Cipla
- Merck
- Cubist Pharmaceuticals
- Abbott Laboratories
- Eli Lilly
- Melinta Therapeutics
- Sanofi
- Daiichi Sankyo
- Lupin
- Apogepha
- Astellas Pharma
- Dr. Dunner
- Kowa
- Jiangxi Jimin Kexin Jinshuibao Pharmaceutical
- Tianjin Tongrentang Group
- Jiangsu Hengrui Pharmaceutical
- Hunan Qianjin Xiang River Pharmaceutical
- Kunming Jida Pharmaceutical
- Jiangsu Lianhuan Pharmaceutical
Outline of Major Chapters:
Chapter 1: Introduces the definition of Urinary System Drugs, market overview.
Chapter 2: Global Urinary System Drugs market size in revenue.
Chapter 3: Detailed analysis of Urinary System Drugs company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Urinary System Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Urinary System Drugs Market, Global Outlook and Forecast 2023-2030 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
110 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Urinary System Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Urinary System Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Urinary System Drugs Overall Market Size
2.1 Global Urinary System Drugs Market Size: 2022 VS 2030
2.2 Global Urinary System Drugs Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Urinary System Drugs Players in Global Market
3.2 Top Global Urinary System Drugs Companies Ranked by Revenue
3.3 Global Urinary System Drugs Revenue by Companies
3.4 Top 3 and Top 5 Urinary System Drugs Companies in Global Market, by Revenue in 2022
3.5 Global Companies Urinary System Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Urinary System Drugs Players in Global Market
3.6.1 List of Global Tier 1 Urinary System Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Urinary System Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Urinary System Drugs Market Size Markets, 2022 & 2030
4.1.2 Injection
4.1.3 Tablets
4.1.4 Capsule
4.1.5 Suppository
4.1.6 Granules
4.1.7 Powder
4.1.8 Pills
4.1.9 Cream
4.1.10 Others
4.2 By Type - Global Urinary System Drugs Revenue & Forecasts
4.2.1 By Type - Global Urinary System Drugs Revenue, 2018-2023
4.2.2 By Type - Global Urinary System Drugs Revenue, 2024-2030
4.2.3 By Type - Global Urinary System Drugs Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Urinary System Drugs Market Size, 2022 & 2030
5.1.2 Kidney Disease Medication
5.1.3 Medication For Prostate Disease
5.1.4 Male Dysfunction
5.1.5 Lithotripsy Drug
5.1.6 Others
5.2 By Application - Global Urinary System Drugs Revenue & Forecasts
5.2.1 By Application - Global Urinary System Drugs Revenue, 2018-2023
5.2.2 By Application - Global Urinary System Drugs Revenue, 2024-2030
5.2.3 By Application - Global Urinary System Drugs Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Urinary System Drugs Market Size, 2022 & 2030
6.2 By Region - Global Urinary System Drugs Revenue & Forecasts
6.2.1 By Region - Global Urinary System Drugs Revenue, 2018-2023
6.2.2 By Region - Global Urinary System Drugs Revenue, 2024-2030
6.2.3 By Region - Global Urinary System Drugs Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Urinary System Drugs Revenue, 2018-2030
6.3.2 US Urinary System Drugs Market Size, 2018-2030
6.3.3 Canada Urinary System Drugs Market Size, 2018-2030
6.3.4 Mexico Urinary System Drugs Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Urinary System Drugs Revenue, 2018-2030
6.4.2 Germany Urinary System Drugs Market Size, 2018-2030
6.4.3 France Urinary System Drugs Market Size, 2018-2030
6.4.4 U.K. Urinary System Drugs Market Size, 2018-2030
6.4.5 Italy Urinary System Drugs Market Size, 2018-2030
6.4.6 Russia Urinary System Drugs Market Size, 2018-2030
6.4.7 Nordic Countries Urinary System Drugs Market Size, 2018-2030
6.4.8 Benelux Urinary System Drugs Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Urinary System Drugs Revenue, 2018-2030
6.5.2 China Urinary System Drugs Market Size, 2018-2030
6.5.3 Japan Urinary System Drugs Market Size, 2018-2030
6.5.4 South Korea Urinary System Drugs Market Size, 2018-2030
6.5.5 Southeast Asia Urinary System Drugs Market Size, 2018-2030
6.5.6 India Urinary System Drugs Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Urinary System Drugs Revenue, 2018-2030
6.6.2 Brazil Urinary System Drugs Market Size, 2018-2030
6.6.3 Argentina Urinary System Drugs Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Urinary System Drugs Revenue, 2018-2030
6.7.2 Turkey Urinary System Drugs Market Size, 2018-2030
6.7.3 Israel Urinary System Drugs Market Size, 2018-2030
6.7.4 Saudi Arabia Urinary System Drugs Market Size, 2018-2030
6.7.5 UAE Urinary System Drugs Market Size, 2018-2030
7 Urinary System Drugs Companies Profiles
7.1 Johnson & Johnson
7.1.1 Johnson & Johnson Company Summary
7.1.2 Johnson & Johnson Business Overview
7.1.3 Johnson & Johnson Urinary System Drugs Major Product Offerings
7.1.4 Johnson & Johnson Urinary System Drugs Revenue in Global Market (2018-2023)
7.1.5 Johnson & Johnson Key News & Latest Developments
7.2 Bayer
7.2.1 Bayer Company Summary
7.2.2 Bayer Business Overview
7.2.3 Bayer Urinary System Drugs Major Product Offerings
7.2.4 Bayer Urinary System Drugs Revenue in Global Market (2018-2023)
7.2.5 Bayer Key News & Latest Developments
7.3 Pfizer
7.3.1 Pfizer Company Summary
7.3.2 Pfizer Business Overview
7.3.3 Pfizer Urinary System Drugs Major Product Offerings
7.3.4 Pfizer Urinary System Drugs Revenue in Global Market (2018-2023)
7.3.5 Pfizer Key News & Latest Developments
7.4 GSK
7.4.1 GSK Company Summary
7.4.2 GSK Business Overview
7.4.3 GSK Urinary System Drugs Major Product Offerings
7.4.4 GSK Urinary System Drugs Revenue in Global Market (2018-2023)
7.4.5 GSK Key News & Latest Developments
7.5 Boehringer Ingelheim
7.5.1 Boehringer Ingelheim Company Summary
7.5.2 Boehringer Ingelheim Business Overview
7.5.3 Boehringer Ingelheim Urinary System Drugs Major Product Offerings
7.5.4 Boehringer Ingelheim Urinary System Drugs Revenue in Global Market (2018-2023)
7.5.5 Boehringer Ingelheim Key News & Latest Developments
7.6 Roche
7.6.1 Roche Company Summary
7.6.2 Roche Business Overview
7.6.3 Roche Urinary System Drugs Major Product Offerings
7.6.4 Roche Urinary System Drugs Revenue in Global Market (2018-2023)
7.6.5 Roche Key News & Latest Developments
7.7 Novartis
7.7.1 Novartis Company Summary
7.7.2 Novartis Business Overview
7.7.3 Novartis Urinary System Drugs Major Product Offerings
7.7.4 Novartis Urinary System Drugs Revenue in Global Market (2018-2023)
7.7.5 Novartis Key News & Latest Developments
7.8 AstraZeneca
7.8.1 AstraZeneca Company Summary
7.8.2 AstraZeneca Business Overview
7.8.3 AstraZeneca Urinary System Drugs Major Product Offerings
7.8.4 AstraZeneca Urinary System Drugs Revenue in Global Market (2018-2023)
7.8.5 AstraZeneca Key News & Latest Developments
7.9 Dr. Reddy?s Laboratories
7.9.1 Dr. Reddy?s Laboratories Company Summary
7.9.2 Dr. Reddy?s Laboratories Business Overview
7.9.3 Dr. Reddy?s Laboratories Urinary System Drugs Major Product Offerings
7.9.4 Dr. Reddy?s Laboratories Urinary System Drugs Revenue in Global Market (2018-2023)
7.9.5 Dr. Reddy?s Laboratories Key News & Latest Developments
7.10 Mylan
7.10.1 Mylan Company Summary
7.10.2 Mylan Business Overview
7.10.3 Mylan Urinary System Drugs Major Product Offerings
7.10.4 Mylan Urinary System Drugs Revenue in Global Market (2018-2023)
7.10.5 Mylan Key News & Latest Developments
7.11 Sun Pharma
7.11.1 Sun Pharma Company Summary
7.11.2 Sun Pharma Business Overview
7.11.3 Sun Pharma Urinary System Drugs Major Product Offerings
7.11.4 Sun Pharma Urinary System Drugs Revenue in Global Market (2018-2023)
7.11.5 Sun Pharma Key News & Latest Developments
7.12 Cipla
7.12.1 Cipla Company Summary
7.12.2 Cipla Business Overview
7.12.3 Cipla Urinary System Drugs Major Product Offerings
7.12.4 Cipla Urinary System Drugs Revenue in Global Market (2018-2023)
7.12.5 Cipla Key News & Latest Developments
7.13 Merck
7.13.1 Merck Company Summary
7.13.2 Merck Business Overview
7.13.3 Merck Urinary System Drugs Major Product Offerings
7.13.4 Merck Urinary System Drugs Revenue in Global Market (2018-2023)
7.13.5 Merck Key News & Latest Developments
7.14 Cubist Pharmaceuticals
7.14.1 Cubist Pharmaceuticals Company Summary
7.14.2 Cubist Pharmaceuticals Business Overview
7.14.3 Cubist Pharmaceuticals Urinary System Drugs Major Product Offerings
7.14.4 Cubist Pharmaceuticals Urinary System Drugs Revenue in Global Market (2018-2023)
7.14.5 Cubist Pharmaceuticals Key News & Latest Developments
7.15 Abbott Laboratories
7.15.1 Abbott Laboratories Company Summary
7.15.2 Abbott Laboratories Business Overview
7.15.3 Abbott Laboratories Urinary System Drugs Major Product Offerings
7.15.4 Abbott Laboratories Urinary System Drugs Revenue in Global Market (2018-2023)
7.15.5 Abbott Laboratories Key News & Latest Developments
7.16 Eli Lilly
7.16.1 Eli Lilly Company Summary
7.16.2 Eli Lilly Business Overview
7.16.3 Eli Lilly Urinary System Drugs Major Product Offerings
7.16.4 Eli Lilly Urinary System Drugs Revenue in Global Market (2018-2023)
7.16.5 Eli Lilly Key News & Latest Developments
7.17 Melinta Therapeutics
7.17.1 Melinta Therapeutics Company Summary
7.17.2 Melinta Therapeutics Business Overview
7.17.3 Melinta Therapeutics Urinary System Drugs Major Product Offerings
7.17.4 Melinta Therapeutics Urinary System Drugs Revenue in Global Market (2018-2023)
7.17.5 Melinta Therapeutics Key News & Latest Developments
7.18 Sanofi
7.18.1 Sanofi Company Summary
7.18.2 Sanofi Business Overview
7.18.3 Sanofi Urinary System Drugs Major Product Offerings
7.18.4 Sanofi Urinary System Drugs Revenue in Global Market (2018-2023)
7.18.5 Sanofi Key News & Latest Developments
7.19 Daiichi Sankyo
7.19.1 Daiichi Sankyo Company Summary
7.19.2 Daiichi Sankyo Business Overview
7.19.3 Daiichi Sankyo Urinary System Drugs Major Product Offerings
7.19.4 Daiichi Sankyo Urinary System Drugs Revenue in Global Market (2018-2023)
7.19.5 Daiichi Sankyo Key News & Latest Developments
7.20 Lupin
7.20.1 Lupin Company Summary
7.20.2 Lupin Business Overview
7.20.3 Lupin Urinary System Drugs Major Product Offerings
7.20.4 Lupin Urinary System Drugs Revenue in Global Market (2018-2023)
7.20.5 Lupin Key News & Latest Developments
7.21 Apogepha
7.21.1 Apogepha Company Summary
7.21.2 Apogepha Business Overview
7.21.3 Apogepha Urinary System Drugs Major Product Offerings
7.21.4 Apogepha Urinary System Drugs Revenue in Global Market (2018-2023)
7.21.5 Apogepha Key News & Latest Developments
7.22 Astellas Pharma
7.22.1 Astellas Pharma Company Summary
7.22.2 Astellas Pharma Business Overview
7.22.3 Astellas Pharma Urinary System Drugs Major Product Offerings
7.22.4 Astellas Pharma Urinary System Drugs Revenue in Global Market (2018-2023)
7.22.5 Astellas Pharma Key News & Latest Developments
7.23 Dr. Dunner
7.23.1 Dr. Dunner Company Summary
7.23.2 Dr. Dunner Business Overview
7.23.3 Dr. Dunner Urinary System Drugs Major Product Offerings
7.23.4 Dr. Dunner Urinary System Drugs Revenue in Global Market (2018-2023)
7.23.5 Dr. Dunner Key News & Latest Developments
7.24 Kowa
7.24.1 Kowa Company Summary
7.24.2 Kowa Business Overview
7.24.3 Kowa Urinary System Drugs Major Product Offerings
7.24.4 Kowa Urinary System Drugs Revenue in Global Market (2018-2023)
7.24.5 Kowa Key News & Latest Developments
7.25 Jiangxi Jimin Kexin Jinshuibao Pharmaceutical
7.25.1 Jiangxi Jimin Kexin Jinshuibao Pharmaceutical Company Summary
7.25.2 Jiangxi Jimin Kexin Jinshuibao Pharmaceutical Business Overview
7.25.3 Jiangxi Jimin Kexin Jinshuibao Pharmaceutical Urinary System Drugs Major Product Offerings
7.25.4 Jiangxi Jimin Kexin Jinshuibao Pharmaceutical Urinary System Drugs Revenue in Global Market (2018-2023)
7.25.5 Jiangxi Jimin Kexin Jinshuibao Pharmaceutical Key News & Latest Developments
7.26 Tianjin Tongrentang Group
7.26.1 Tianjin Tongrentang Group Company Summary
7.26.2 Tianjin Tongrentang Group Business Overview
7.26.3 Tianjin Tongrentang Group Urinary System Drugs Major Product Offerings
7.26.4 Tianjin Tongrentang Group Urinary System Drugs Revenue in Global Market (2018-2023)
7.26.5 Tianjin Tongrentang Group Key News & Latest Developments
7.27 Jiangsu Hengrui Pharmaceutical
7.27.1 Jiangsu Hengrui Pharmaceutical Company Summary
7.27.2 Jiangsu Hengrui Pharmaceutical Business Overview
7.27.3 Jiangsu Hengrui Pharmaceutical Urinary System Drugs Major Product Offerings
7.27.4 Jiangsu Hengrui Pharmaceutical Urinary System Drugs Revenue in Global Market (2018-2023)
7.27.5 Jiangsu Hengrui Pharmaceutical Key News & Latest Developments
7.28 Hunan Qianjin Xiang River Pharmaceutical
7.28.1 Hunan Qianjin Xiang River Pharmaceutical Company Summary
7.28.2 Hunan Qianjin Xiang River Pharmaceutical Business Overview
7.28.3 Hunan Qianjin Xiang River Pharmaceutical Urinary System Drugs Major Product Offerings
7.28.4 Hunan Qianjin Xiang River Pharmaceutical Urinary System Drugs Revenue in Global Market (2018-2023)
7.28.5 Hunan Qianjin Xiang River Pharmaceutical Key News & Latest Developments
7.29 Kunming Jida Pharmaceutical
7.29.1 Kunming Jida Pharmaceutical Company Summary
7.29.2 Kunming Jida Pharmaceutical Business Overview
7.29.3 Kunming Jida Pharmaceutical Urinary System Drugs Major Product Offerings
7.29.4 Kunming Jida Pharmaceutical Urinary System Drugs Revenue in Global Market (2018-2023)
7.29.5 Kunming Jida Pharmaceutical Key News & Latest Developments
7.30 Jiangsu Lianhuan Pharmaceutical
7.30.1 Jiangsu Lianhuan Pharmaceutical Company Summary
7.30.2 Jiangsu Lianhuan Pharmaceutical Business Overview
7.30.3 Jiangsu Lianhuan Pharmaceutical Urinary System Drugs Major Product Offerings
7.30.4 Jiangsu Lianhuan Pharmaceutical Urinary System Drugs Revenue in Global Market (2018-2023)
7.30.5 Jiangsu Lianhuan Pharmaceutical Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Urinary System Drugs Market Opportunities & Trends in Global Market
Table 2. Urinary System Drugs Market Drivers in Global Market
Table 3. Urinary System Drugs Market Restraints in Global Market
Table 4. Key Players of Urinary System Drugs in Global Market
Table 5. Top Urinary System Drugs Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Urinary System Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Urinary System Drugs Revenue Share by Companies, 2018-2023
Table 8. Global Companies Urinary System Drugs Product Type
Table 9. List of Global Tier 1 Urinary System Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Urinary System Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Urinary System Drugs Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Urinary System Drugs Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Urinary System Drugs Revenue in Global (US$, Mn), 2024-2030
Table 14. By Application ? Global Urinary System Drugs Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - Urinary System Drugs Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Urinary System Drugs Revenue in Global (US$, Mn), 2024-2030
Table 17. By Region ? Global Urinary System Drugs Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global Urinary System Drugs Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Urinary System Drugs Revenue (US$, Mn), 2024-2030
Table 20. By Country - North America Urinary System Drugs Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Urinary System Drugs Revenue, (US$, Mn), 2024-2030
Table 22. By Country - Europe Urinary System Drugs Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Urinary System Drugs Revenue, (US$, Mn), 2024-2030
Table 24. By Region - Asia Urinary System Drugs Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Urinary System Drugs Revenue, (US$, Mn), 2024-2030
Table 26. By Country - South America Urinary System Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Urinary System Drugs Revenue, (US$, Mn), 2024-2030
Table 28. By Country - Middle East & Africa Urinary System Drugs Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Urinary System Drugs Revenue, (US$, Mn), 2024-2030
Table 30. Johnson & Johnson Company Summary
Table 31. Johnson & Johnson Urinary System Drugs Product Offerings
Table 32. Johnson & Johnson Urinary System Drugs Revenue (US$, Mn) & (2018-2023)
Table 33. Johnson & Johnson Key News & Latest Developments
Table 34. Bayer Company Summary
Table 35. Bayer Urinary System Drugs Product Offerings
Table 36. Bayer Urinary System Drugs Revenue (US$, Mn) & (2018-2023)
Table 37. Bayer Key News & Latest Developments
Table 38. Pfizer Company Summary
Table 39. Pfizer Urinary System Drugs Product Offerings
Table 40. Pfizer Urinary System Drugs Revenue (US$, Mn) & (2018-2023)
Table 41. Pfizer Key News & Latest Developments
Table 42. GSK Company Summary
Table 43. GSK Urinary System Drugs Product Offerings
Table 44. GSK Urinary System Drugs Revenue (US$, Mn) & (2018-2023)
Table 45. GSK Key News & Latest Developments
Table 46. Boehringer Ingelheim Company Summary
Table 47. Boehringer Ingelheim Urinary System Drugs Product Offerings
Table 48. Boehringer Ingelheim Urinary System Drugs Revenue (US$, Mn) & (2018-2023)
Table 49. Boehringer Ingelheim Key News & Latest Developments
Table 50. Roche Company Summary
Table 51. Roche Urinary System Drugs Product Offerings
Table 52. Roche Urinary System Drugs Revenue (US$, Mn) & (2018-2023)
Table 53. Roche Key News & Latest Developments
Table 54. Novartis Company Summary
Table 55. Novartis Urinary System Drugs Product Offerings
Table 56. Novartis Urinary System Drugs Revenue (US$, Mn) & (2018-2023)
Table 57. Novartis Key News & Latest Developments
Table 58. AstraZeneca Company Summary
Table 59. AstraZeneca Urinary System Drugs Product Offerings
Table 60. AstraZeneca Urinary System Drugs Revenue (US$, Mn) & (2018-2023)
Table 61. AstraZeneca Key News & Latest Developments
Table 62. Dr. Reddy?s Laboratories Company Summary
Table 63. Dr. Reddy?s Laboratories Urinary System Drugs Product Offerings
Table 64. Dr. Reddy?s Laboratories Urinary System Drugs Revenue (US$, Mn) & (2018-2023)
Table 65. Dr. Reddy?s Laboratories Key News & Latest Developments
Table 66. Mylan Company Summary
Table 67. Mylan Urinary System Drugs Product Offerings
Table 68. Mylan Urinary System Drugs Revenue (US$, Mn) & (2018-2023)
Table 69. Mylan Key News & Latest Developments
Table 70. Sun Pharma Company Summary
Table 71. Sun Pharma Urinary System Drugs Product Offerings
Table 72. Sun Pharma Urinary System Drugs Revenue (US$, Mn) & (2018-2023)
Table 73. Sun Pharma Key News & Latest Developments
Table 74. Cipla Company Summary
Table 75. Cipla Urinary System Drugs Product Offerings
Table 76. Cipla Urinary System Drugs Revenue (US$, Mn) & (2018-2023)
Table 77. Cipla Key News & Latest Developments
Table 78. Merck Company Summary
Table 79. Merck Urinary System Drugs Product Offerings
Table 80. Merck Urinary System Drugs Revenue (US$, Mn) & (2018-2023)
Table 81. Merck Key News & Latest Developments
Table 82. Cubist Pharmaceuticals Company Summary
Table 83. Cubist Pharmaceuticals Urinary System Drugs Product Offerings
Table 84. Cubist Pharmaceuticals Urinary System Drugs Revenue (US$, Mn) & (2018-2023)
Table 85. Cubist Pharmaceuticals Key News & Latest Developments
Table 86. Abbott Laboratories Company Summary
Table 87. Abbott Laboratories Urinary System Drugs Product Offerings
Table 88. Abbott Laboratories Urinary System Drugs Revenue (US$, Mn) & (2018-2023)
Table 89. Abbott Laboratories Key News & Latest Developments
Table 90. Eli Lilly Company Summary
Table 91. Eli Lilly Urinary System Drugs Product Offerings
Table 92. Eli Lilly Urinary System Drugs Revenue (US$, Mn) & (2018-2023)
Table 93. Eli Lilly Key News & Latest Developments
Table 94. Melinta Therapeutics Company Summary
Table 95. Melinta Therapeutics Urinary System Drugs Product Offerings
Table 96. Melinta Therapeutics Urinary System Drugs Revenue (US$, Mn) & (2018-2023)
Table 97. Melinta Therapeutics Key News & Latest Developments
Table 98. Sanofi Company Summary
Table 99. Sanofi Urinary System Drugs Product Offerings
Table 100. Sanofi Urinary System Drugs Revenue (US$, Mn) & (2018-2023)
Table 101. Sanofi Key News & Latest Developments
Table 102. Daiichi Sankyo Company Summary
Table 103. Daiichi Sankyo Urinary System Drugs Product Offerings
Table 104. Daiichi Sankyo Urinary System Drugs Revenue (US$, Mn) & (2018-2023)
Table 105. Daiichi Sankyo Key News & Latest Developments
Table 106. Lupin Company Summary
Table 107. Lupin Urinary System Drugs Product Offerings
Table 108. Lupin Urinary System Drugs Revenue (US$, Mn) & (2018-2023)
Table 109. Lupin Key News & Latest Developments
Table 110. Apogepha Company Summary
Table 111. Apogepha Urinary System Drugs Product Offerings
Table 112. Apogepha Urinary System Drugs Revenue (US$, Mn) & (2018-2023)
Table 113. Apogepha Key News & Latest Developments
Table 114. Astellas Pharma Company Summary
Table 115. Astellas Pharma Urinary System Drugs Product Offerings
Table 116. Astellas Pharma Urinary System Drugs Revenue (US$, Mn) & (2018-2023)
Table 117. Astellas Pharma Key News & Latest Developments
Table 118. Dr. Dunner Company Summary
Table 119. Dr. Dunner Urinary System Drugs Product Offerings
Table 120. Dr. Dunner Urinary System Drugs Revenue (US$, Mn) & (2018-2023)
Table 121. Dr. Dunner Key News & Latest Developments
Table 122. Kowa Company Summary
Table 123. Kowa Urinary System Drugs Product Offerings
Table 124. Kowa Urinary System Drugs Revenue (US$, Mn) & (2018-2023)
Table 125. Kowa Key News & Latest Developments
Table 126. Jiangxi Jimin Kexin Jinshuibao Pharmaceutical Company Summary
Table 127. Jiangxi Jimin Kexin Jinshuibao Pharmaceutical Urinary System Drugs Product Offerings
Table 128. Jiangxi Jimin Kexin Jinshuibao Pharmaceutical Urinary System Drugs Revenue (US$, Mn) & (2018-2023)
Table 129. Jiangxi Jimin Kexin Jinshuibao Pharmaceutical Key News & Latest Developments
Table 130. Tianjin Tongrentang Group Company Summary
Table 131. Tianjin Tongrentang Group Urinary System Drugs Product Offerings
Table 132. Tianjin Tongrentang Group Urinary System Drugs Revenue (US$, Mn) & (2018-2023)
Table 133. Tianjin Tongrentang Group Key News & Latest Developments
Table 134. Jiangsu Hengrui Pharmaceutical Company Summary
Table 135. Jiangsu Hengrui Pharmaceutical Urinary System Drugs Product Offerings
Table 136. Jiangsu Hengrui Pharmaceutical Urinary System Drugs Revenue (US$, Mn) & (2018-2023)
Table 137. Jiangsu Hengrui Pharmaceutical Key News & Latest Developments
Table 138. Hunan Qianjin Xiang River Pharmaceutical Company Summary
Table 139. Hunan Qianjin Xiang River Pharmaceutical Urinary System Drugs Product Offerings
Table 140. Hunan Qianjin Xiang River Pharmaceutical Urinary System Drugs Revenue (US$, Mn) & (2018-2023)
Table 141. Hunan Qianjin Xiang River Pharmaceutical Key News & Latest Developments
Table 142. Kunming Jida Pharmaceutical Company Summary
Table 143. Kunming Jida Pharmaceutical Urinary System Drugs Product Offerings
Table 144. Kunming Jida Pharmaceutical Urinary System Drugs Revenue (US$, Mn) & (2018-2023)
Table 145. Kunming Jida Pharmaceutical Key News & Latest Developments
Table 146. Jiangsu Lianhuan Pharmaceutical Company Summary
Table 147. Jiangsu Lianhuan Pharmaceutical Urinary System Drugs Product Offerings
Table 148. Jiangsu Lianhuan Pharmaceutical Urinary System Drugs Revenue (US$, Mn) & (2018-2023)
Table 149. Jiangsu Lianhuan Pharmaceutical Key News & Latest Developments
List of Figures
Figure 1. Urinary System Drugs Segment by Type in 2022
Figure 2. Urinary System Drugs Segment by Application in 2022
Figure 3. Global Urinary System Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Urinary System Drugs Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Urinary System Drugs Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Urinary System Drugs Revenue in 2022
Figure 8. By Type - Global Urinary System Drugs Revenue Market Share, 2018-2030
Figure 9. By Application - Global Urinary System Drugs Revenue Market Share, 2018-2030
Figure 10. By Type - Global Urinary System Drugs Revenue, (US$, Mn), 2022 & 2030
Figure 11. By Type - Global Urinary System Drugs Revenue Market Share, 2018-2030
Figure 12. By Application - Global Urinary System Drugs Revenue, (US$, Mn), 2022 & 2030
Figure 13. By Application - Global Urinary System Drugs Revenue Market Share, 2018-2030
Figure 14. By Region - Global Urinary System Drugs Revenue Market Share, 2018-2030
Figure 15. By Country - North America Urinary System Drugs Revenue Market Share, 2018-2030
Figure 16. US Urinary System Drugs Revenue, (US$, Mn), 2018-2030
Figure 17. Canada Urinary System Drugs Revenue, (US$, Mn), 2018-2030
Figure 18. Mexico Urinary System Drugs Revenue, (US$, Mn), 2018-2030
Figure 19. By Country - Europe Urinary System Drugs Revenue Market Share, 2018-2030
Figure 20. Germany Urinary System Drugs Revenue, (US$, Mn), 2018-2030
Figure 21. France Urinary System Drugs Revenue, (US$, Mn), 2018-2030
Figure 22. U.K. Urinary System Drugs Revenue, (US$, Mn), 2018-2030
Figure 23. Italy Urinary System Drugs Revenue, (US$, Mn), 2018-2030
Figure 24. Russia Urinary System Drugs Revenue, (US$, Mn), 2018-2030
Figure 25. Nordic Countries Urinary System Drugs Revenue, (US$, Mn), 2018-2030
Figure 26. Benelux Urinary System Drugs Revenue, (US$, Mn), 2018-2030
Figure 27. By Region - Asia Urinary System Drugs Revenue Market Share, 2018-2030
Figure 28. China Urinary System Drugs Revenue, (US$, Mn), 2018-2030
Figure 29. Japan Urinary System Drugs Revenue, (US$, Mn), 2018-2030
Figure 30. South Korea Urinary System Drugs Revenue, (US$, Mn), 2018-2030
Figure 31. Southeast Asia Urinary System Drugs Revenue, (US$, Mn), 2018-2030
Figure 32. India Urinary System Drugs Revenue, (US$, Mn), 2018-2030
Figure 33. By Country - South America Urinary System Drugs Revenue Market Share, 2018-2030
Figure 34. Brazil Urinary System Drugs Revenue, (US$, Mn), 2018-2030
Figure 35. Argentina Urinary System Drugs Revenue, (US$, Mn), 2018-2030
Figure 36. By Country - Middle East & Africa Urinary System Drugs Revenue Market Share, 2018-2030
Figure 37. Turkey Urinary System Drugs Revenue, (US$, Mn), 2018-2030
Figure 38. Israel Urinary System Drugs Revenue, (US$, Mn), 2018-2030
Figure 39. Saudi Arabia Urinary System Drugs Revenue, (US$, Mn), 2018-2030
Figure 40. UAE Urinary System Drugs Revenue, (US$, Mn), 2018-2030
Figure 41. Johnson & Johnson Urinary System Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Bayer Urinary System Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Pfizer Urinary System Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. GSK Urinary System Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Boehringer Ingelheim Urinary System Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Roche Urinary System Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Novartis Urinary System Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. AstraZeneca Urinary System Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Dr. Reddy?s Laboratories Urinary System Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Mylan Urinary System Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Sun Pharma Urinary System Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Cipla Urinary System Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. Merck Urinary System Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 54. Cubist Pharmaceuticals Urinary System Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 55. Abbott Laboratories Urinary System Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 56. Eli Lilly Urinary System Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 57. Melinta Therapeutics Urinary System Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 58. Sanofi Urinary System Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 59. Daiichi Sankyo Urinary System Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 60. Lupin Urinary System Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 61. Apogepha Urinary System Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 62. Astellas Pharma Urinary System Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 63. Dr. Dunner Urinary System Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 64. Kowa Urinary System Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 65. Jiangxi Jimin Kexin Jinshuibao Pharmaceutical Urinary System Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 66. Tianjin Tongrentang Group Urinary System Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 67. Jiangsu Hengrui Pharmaceutical Urinary System Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 68. Hunan Qianjin Xiang River Pharmaceutical Urinary System Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 69. Kunming Jida Pharmaceutical Urinary System Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 70. Jiangsu Lianhuan Pharmaceutical Urinary System Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
